Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Sangstat initiates cyclosporine and azathioprine bioequivalence trials

Aug. 9, 1996

Peptech's PTL-78419 covered under U.S. and European patents

Aug. 9, 1996

SangStat's Thymoglobulin nearing phase III trials completion

Aug. 9, 1996

Peptech issued U.S. patent for GMDP as antiinflammatory agent

Aug. 9, 1996

American Home Products claims rapamycin compounds

Aug. 9, 1996

Immunostimulant series described by Takeda

Aug. 9, 1996

Biogal describes cyclosporin emulsions

July 26, 1996

Rapamycin esters from American Home Products

July 26, 1996

Immunoregulatory peptides with special binding properties

July 26, 1996

HSV proteins as immune resonse regulators

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...